{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:02:57Z","timestamp":1793134977161,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T00:00:00Z","timestamp":1490400000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10096-017-2960-5","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T04:11:48Z","timestamp":1490415108000},"page":"1511-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Predictive score of haematological toxicity in patients treated with linezolid"],"prefix":"10.1007","volume":"36","author":[{"name":"Representatives of the Emergency Department Investigation Unit (addendum)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez-Del Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"Candel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Manzano-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Garc\u00eda-Lamberechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"Mart\u00edn-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,25]]},"reference":[{"key":"2960_CR1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2016.06.010","volume":"48","author":"M Zhao","year":"2016","unstructured":"Zhao M, Liang L, Ji L, Chen D, Zhang Y, Zhu Y, Patel K (2016) Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis. Int J Antimicrob Agents 48:231\u2013238","journal-title":"Int J Antimicrob Agents"},{"key":"2960_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-200059010-00002","volume":"59","author":"DI Diekema","year":"2000","unstructured":"Diekema DI, Jones RN (2000) Oxazolidinones: a review. Drugs 59:7\u201316","journal-title":"Drugs"},{"key":"2960_CR3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/338403","volume":"34","author":"K Attassi","year":"2002","unstructured":"Attassi K, Hershberger E, Alam R, Zervos MJ (2002) Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 34:695\u2013698","journal-title":"Clin Infect Dis"},{"key":"2960_CR4","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1592\/phco.21.11.1010.34517","volume":"21","author":"DJ Kuter","year":"2001","unstructured":"Kuter DJ, Tillotson GS (2001) Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy 21:1010\u20131013","journal-title":"Pharmacotherapy"},{"key":"2960_CR5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s10096-013-2041-3","volume":"33","author":"HY Dong","year":"2014","unstructured":"Dong HY, Xie J, Chen LH (2014) Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients. Eur J Clin Microbiol Infect Dis 33:1029\u201335","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2960_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.curtheres.2012.07.002","volume":"73","author":"C Chen","year":"2012","unstructured":"Chen C, Guo DH, Cao X (2012) Risk factors for thrombocytopenia in adult Chinese patients receiving linezolid therapy. Curr Ther Res Clin Exp 73:195\u2013206","journal-title":"Curr Ther Res Clin Exp"},{"key":"2960_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s11096-014-9961-6","volume":"36","author":"R Hirano","year":"2014","unstructured":"Hirano R, Sakamoto Y, Tachibana N (2014) Retrospective analysis of the risk factors for linezolid-induced thrombocytopenia in adult Japanese patients. Int J Clin Pharm 36:795\u20139","journal-title":"Int J Clin Pharm"},{"key":"2960_CR8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s15010-014-0674-5","volume":"42","author":"B Natsumoto","year":"2014","unstructured":"Natsumoto B, Yokota K, Omata F, Furukawa K (2014) Risk factors for linezolid-associated thrombocytopenia in adult patients. Infection 42:1007\u20131012","journal-title":"Infection"},{"key":"2960_CR9","first-page":"837","volume":"29","author":"LQ Bi","year":"2013","unstructured":"Bi LQ, Zhou J, Huang M, Zhou SM (2013) Efficacy of linezolid on gram-positive bacterial infection in elderly patients and the risk factors associated with thrombocytopenia. Pak J Med Sci 29:837\u2013842","journal-title":"Pak J Med Sci"},{"key":"2960_CR10","first-page":"320","volume":"39","author":"L Moraza","year":"2015","unstructured":"Moraza L, Leache L, Aquerreta I, Ortega A (2015) Linezolid-induced haematological toxicity. Farm Hosp 39:320\u2013326","journal-title":"Farm Hosp"},{"key":"2960_CR11","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.00247-07","volume":"51","author":"A Soriano","year":"2007","unstructured":"Soriano A, Ortega M, Garcia S, Penarroja G, Bove A, Marcos M et al (2007) Comparative study of the effects of pyridoxine, rifampin, and renal function on hematological adverse events induced by linezolid. Antimicrob Agents Chemother 51:2559\u20132563","journal-title":"Antimicrob Agents Chemother"},{"key":"2960_CR12","first-page":"89","volume":"28","author":"S Tom\u00e1s Vecina","year":"2016","unstructured":"Tom\u00e1s Vecina S, Mozota Duarte J, Ortega Marcos M, Ruiz Navarro MG, Borillo V, San Juan GL et al (2016) Peripheral venous catheter use in the emergency department: reducing adverse events in patients and biosafety problems for staff. Emergencias 28:89\u201396","journal-title":"Emergencias"},{"key":"2960_CR13","first-page":"141","volume":"28","author":"M Tejedor Fern\u00e1ndez","year":"2016","unstructured":"Tejedor Fern\u00e1ndez M, Ferrer Higueras MJ, Tejedor BR (2016) Patient safety, clinical outcomes, and efficiency in the emergency department. Emergencias 28:141\u20132","journal-title":"Emergencias"},{"key":"2960_CR14","first-page":"229","volume":"28","author":"E Moncl\u00fas Cols","year":"2016","unstructured":"Moncl\u00fas Cols E, Capdevila Reniu A, Roedberg Ramos D, Pujol Fontrodona G, Ortega RM (2016) Management of severe sepsis and septic shock in a tertiary care urban hospital emergency department: opportunities for improvement. Emergencias 28:229\u201334","journal-title":"Emergencias"},{"key":"2960_CR15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcrc.2011.08.021","volume":"27","author":"S Oltean","year":"2012","unstructured":"Oltean S, Tatulescu D, Bondor C, Slavcovici A, Cismaru C, Lupse M et al (2012) Charlson\u2019s weighted index of comorbidities is useful in assessing the risk of death in septic patients. J Crit Care 27:370\u2013375","journal-title":"J Crit Care"},{"key":"2960_CR16","unstructured":"U.S. Department of Health and Human Services (2010) Common terminology criteria for adverse events (CTCAE), version 4.0. 2009 (v4.03: June 14, 2010). National Institutes of Health. National Cancer Institute. Available at: \nhttp:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CT-CAE_4.03_2010-06-14_QuickReference_5x7.pdf"},{"key":"2960_CR17","first-page":"381","volume":"28","author":"B G\u00f3mez-Alonso","year":"2016","unstructured":"G\u00f3mez-Alonso B, Rodr\u00edguez-\u00c1lvarez C, Castro Hern\u00e1ndez B, Arias Rodr\u00edguez A, Aguirre-Jaime A, Lecuona FM (2016) Hospital emergency health service care as a risk factor for methicillin-resistant Staphylococcus aureus in residents of long-term care facilities. Emergencias 28:381\u20136","journal-title":"Emergencias"},{"key":"2960_CR18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/AAC.03688-14","volume":"59","author":"AF Shorr","year":"2015","unstructured":"Shorr AF, Lodise TP, Corey GR, De Anda C, Fang E, Das AF et al (2015) Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections. Antimicrob Agents Chemother 59:864\u201371","journal-title":"Antimicrob Agents Chemother"},{"key":"2960_CR19","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1128\/AAC.05738-11","volume":"56","author":"HD Friedland","year":"2012","unstructured":"Friedland HD, O\u2019Neal T, Biek D, Eckburg PB, Rank DR, Llorens L et al (2012) CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections. Antimicrob Agents Chemother 56:2231\u20136","journal-title":"Antimicrob Agents Chemother"},{"key":"2960_CR20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","volume":"62","author":"MW Dunne","year":"2016","unstructured":"Dunne MW, Puttagunta S, Giordano P, Krievins D, Zelasky M, Baldassarre J (2016) A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection. Clin Infect Dis 62:545\u201351","journal-title":"Clin Infect Dis"},{"key":"2960_CR21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s10156-010-0188-8","volume":"17","author":"S Ikuta","year":"2011","unstructured":"Ikuta S, Tanimura K, Yasui C, Aihara T, Yoshie H, Iida H et al (2011) Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery. J Infect Chemother 17:388\u201391","journal-title":"J Infect Chemother"},{"key":"2960_CR22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijantimicag.2008.07.002","volume":"33","author":"K Matsumoto","year":"2009","unstructured":"Matsumoto K, Takeda Y, Takeshita A et al (2009) Renal function as a predictor of linezolid-induced thrombocytopenia. Int J Antimicrob Agents 33:98\u20139","journal-title":"Int J Antimicrob Agents"},{"key":"2960_CR23","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/jac\/dkt133","volume":"68","author":"Y Nukui","year":"2013","unstructured":"Nukui Y, Hatakeyama S, Okamoto K et al (2013) High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J Antimicrob Chemother 68:2128\u201333","journal-title":"J Antimicrob Chemother"},{"key":"2960_CR24","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.01185-10","volume":"55","author":"T Sasaki","year":"2011","unstructured":"Sasaki T, Takane H, Ogawa K, Isagawa S, Hirota T, Higuchi S et al (2011) Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients. Antimicrob Agents Chemother 55:1867\u201373","journal-title":"Antimicrob Agents Chemother"},{"key":"2960_CR25","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2008.03.009","volume":"48","author":"N Afdhal","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F et al (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48:1000\u20137","journal-title":"J Hepatol"},{"key":"2960_CR26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2217\/pgs.16.21","volume":"17","author":"L Milanowski","year":"2016","unstructured":"Milanowski L, Pordzik J, Janicki PK, Postula M (2016) Common genetic variants in platelet surface receptors and its association with ischemic stroke. Pharmacogenomics 17:953\u201371","journal-title":"Pharmacogenomics"},{"key":"2960_CR27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MAJ.0b013e31818af6de","volume":"337","author":"R Keshet","year":"2009","unstructured":"Keshet R, Boursi B, Maoz R, Shnell M, Guzner-Gur H (2009) Diagnostic and prognostic significance of serum C-reactive protein levels in patients admitted to the department of medicine. Am J Med Sci 337:248\u201355","journal-title":"Am J Med Sci"},{"key":"2960_CR28","first-page":"73","volume":"27","author":"FJ Mart\u00edn-S\u00e1nchez","year":"2015","unstructured":"Mart\u00edn-S\u00e1nchez FJ, Gonz\u00e1lez Del Castillo J (2015) Sepsis en el anciano: \u00bfest\u00e1n preparados los servicios de urgencias hospitalarios? Emergencias 27:73\u20134","journal-title":"Emergencias"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-2960-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2960-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2960-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T07:31:43Z","timestamp":1500881503000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-2960-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,25]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["2960"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-2960-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,25]]}}}